dbSNP rs9320182: CRYBG1:c.*2846C>T (chr6-106571412-C-T) – ACMG Classification: Benign (-12 pts)

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001371242.2(CRYBG1):c.*2846C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.163 in 152,378 control chromosomes in the GnomAD database, including 2,477 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.16 ( 2476 hom., cov: 32)

Exomes 𝑓: 0.11 ( 1 hom. )

Consequence

CRYBG1
NM_001371242.2 3_prime_UTR

Scores

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.597

Publications

6 publications found

Variant links:

Genes affected

CRYBG1 (HGNC:356): (crystallin beta-gamma domain containing 1) Predicted to enable carbohydrate binding activity. [provided by Alliance of Genome Resources, Apr 2022]

CRYBG1 links:

RTN4IP1 (HGNC:18647): (reticulon 4 interacting protein 1) This gene encodes a mitochondrial protein that interacts with reticulon 4, which is a potent inhibitor of regeneration following spinal cord injury. This interaction may be important for reticulon-induced inhibition of neurite growth. Mutations in this gene can cause optic atrophy 10, with or without ataxia, cognitive disability, and seizures. There is a pseudogene for this gene on chromosome 12. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2016]

RTN4IP1 Gene-Disease associations (from GenCC):

optic atrophy 10 with or without ataxia, intellectual disability, and seizures
Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
autosomal recessive optic atrophy
Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

RTN4IP1 links:

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4

Computational evidence support a benign effect (BayesDel_noAF=-0.92).

BA1

GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.277 is higher than 0.05.

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CRYBG1	NM_001371242.2 link	c.*2846C>T		3_prime_UTR_variant	Exon 22 of 22	ENST00000633556.3	NP_001358171.1
RTN4IP1	NM_032730.5 link	c.*584G>A		3_prime_UTR_variant	Exon 9 of 9	ENST00000369063.8	NP_116119.2	Q8WWV3-1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CRYBG1	ENST00000633556.3 link	c.*2846C>T		3_prime_UTR_variant	Exon 22 of 22	5	NM_001371242.2	ENSP00000488010.2		A0A0J9YWL0
RTN4IP1	ENST00000369063.8 link	c.*584G>A		3_prime_UTR_variant	Exon 9 of 9	1	NM_032730.5	ENSP00000358059.3		Q8WWV3-1

Frequencies

GnomAD3 genomes

AF:

0.163

AC:

24744

AN:

151988

Hom.:

2474

Cov.:

show subpopulations

Gnomad AFR

AF:

0.282

Gnomad AMI

AF:

0.0877

Gnomad AMR

AF:

0.132

Gnomad ASJ

AF:

0.127

Gnomad EAS

AF:

0.142

Gnomad SAS

AF:

0.133

Gnomad FIN

AF:

0.123

Gnomad MID

AF:

0.188

Gnomad NFE

AF:

0.110

Gnomad OTH

AF:

0.164

GnomAD4 exome

AF:

0.107

AC:

AN:

272

Hom.:

Cov.:

AF XY:

0.109

AC XY:

AN XY:

156

show subpopulations

African (AFR)

AF:

0.250

AC:

AN:

American (AMR)

AF:

0.111

AC:

AN:

Ashkenazi Jewish (ASJ)

AC:

AN:

East Asian (EAS)

AF:

0.100

AC:

AN:

South Asian (SAS)

AC:

AN:

European-Finnish (FIN)

AF:

0.167

AC:

AN:

Middle Eastern (MID)

AC:

AN:

European-Non Finnish (NFE)

AF:

0.0957

AC:

AN:

230

Other (OTH)

AF:

0.500

AC:

AN:

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.468

Heterozygous variant carriers

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Exome Het

Variant carriers

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

GnomAD4 genome

AF:

0.163

AC:

24751

AN:

152106

Hom.:

2476

Cov.:

AF XY:

0.162

AC XY:

12022

AN XY:

74380

show subpopulations

African (AFR)

AF:

0.282

AC:

11669

AN:

41450

American (AMR)

AF:

0.131

AC:

2011

AN:

15300

Ashkenazi Jewish (ASJ)

AF:

0.127

AC:

439

AN:

3470

East Asian (EAS)

AF:

0.142

AC:

735

AN:

5176

South Asian (SAS)

AF:

0.133

AC:

640

AN:

4820

European-Finnish (FIN)

AF:

0.123

AC:

1305

AN:

10586

Middle Eastern (MID)

AF:

0.182

AC:

AN:

292

European-Non Finnish (NFE)

AF:

0.110

AC:

7474

AN:

67986

Other (OTH)

AF:

0.163

AC:

345

AN:

2114

Allele Balance Distribution

Red line indicates average allele balance

Average allele balance: 0.501

Heterozygous variant carriers

1035

2069

3104

4138

5173

0.00

0.20

0.40

0.60

0.80

0.95

Allele balance

Age Distribution

Genome Het

Genome Hom

Variant carriers

252

504

756

1008

1260

<30

30-35

35-40

40-45

45-50

50-55

55-60

60-65

65-70

70-75

75-80

>80

Age

Alfa

AF:

0.133

Hom.:

4232

Bravo

AF:

0.169

Asia WGS

AF:

0.155

AC:

542

AN:

3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name

Calibrated prediction

Score

Prediction

BayesDel_noAF

Benign

-0.92

CADD

Benign

1.2

(source)

DANN

Benign

0.47

PhyloP100

-0.60

Mutation Taster

=100/0

polymorphism (auto)

(source)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.

Variant summary

Frequency

Consequence

Scores

Clinical Significance

Conservation

Publications

ACMG classification

Transcripts

RefSeq

Ensembl

Frequencies

Age Distribution

Age Distribution

ClinVar

Computational scores

Splicing

Publications

Other links and lift over